Abiopharma

🔍 Kramer Andrea Anigati (Executive)

Company: Hamilton Lane INC (HLNE)

Report Date: 2026-06-11

Detailed Transactions and Holdings:

• Acquired 1,283 shares of Class A Common Stock at $77.46 per share (Direct)
  Date: 2026-06-11 | Code: P | equity_swap_involved: 0 | shares_owned_after: 87,350.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class B Common Stock (Direct)
  Date: 2026-06-11 | Code: H | shares_owned_after: 135,970.00 | Footnotes: F2
• Holds 5,435 shares of Performance Stock (Derivative)
  Date: 2026-06-11 | Code: H | shares_owned_after: 5,435.00 | Footnotes: F3, F3, F3
• Holds 2,033 shares of Performance Stock (Derivative)
  Date: 2026-06-11 | Code: H | shares_owned_after: 2,033.00 | Footnotes: F4, F4, F4
• Holds 13,044 shares of Performance Stock (Derivative)
  Date: 2026-06-11 | Code: H | shares_owned_after: 13,044.00 | Footnotes: F5, F5, F5
• Holds 135,970 shares of Class B Units (Derivative)
  Date: 2026-06-11 | Code: H | shares_owned_after: 135,970.00 | Footnotes: F6, F6, F6, F7
• Holds 195,317 shares of Class C Units (Derivative)
  Date: 2026-06-11 | Code: H | shares_owned_after: 195,317.00 | Footnotes: F6, F6, F6, F7

Footnotes:

• F1: Includes unvested restricted stock granted under the Issuer's 2017 Equity Incentive Plan.
• F2: The Class B common stock does not carry economic value beyond the right to receive the par value of such stock upon liquidation, dissolution or exchange of those shares. However, the Class B common stock entitles its holder to ten votes per share on every matter submitted to the Issuer's stockholders for a vote.
• F3: Each share of performance stock represents a contingent right to receive one Class A Share. The performance stock vests upon the Issuer's Class A Shares achieving a specified price per share. The performance period of the performance stock ends on September 16, 2031.
• F4: Each share of performance stock represents a contingent right to receive one Class A Share of the Issuer. The performance stock vests at the end of the performance period if the Issuer's Class A Shares achieves a specified growth rate of TSR over the performance period. The performance period of the performance stock ends on September 16, 2030.
• F5: Each share of performance stock represents a contingent right to receive one Class A Share. The performance stock vests upon the Issuer's Class A Shares achieving a specified price per share. The performance period of the performance stock ends on September 16, 2029.
• F6: Pursuant to an Exchange Agreement entered into in connection with a reorganization incident to the Issuer's initial public offering, the Class B Units and Class C Units of Hamilton Lane Advisors, L.L.C. ("HLA") are exchangeable, on a one-for-one basis, for Class A Shares or, at the Issuer's election, for cash. Upon exchange of a Class B Unit, the corresponding share of Class B common stock will be redeemed at par value and cancelled. The Class B Units and Class C Units of HLA do not have an expiration date.
• F7: Held on behalf of the reporting person by HL Management Investors, LLC.
• REMARKS: In addition to serving as an officer of the Issuer, the reporting person is a member of a group that beneficially owns more than 10% of the Issuer's Class A Shares.